Finally, the BCR–ABL1-negative MPN driver mutations—that is, in JAK2, MPL, and CALR genes—seem to be able to accompany other alterations, conditioning the onset of an inflammatory state. This evidence concerns the gene CALR and myeloproliferative disorder.